What Does MACD Oscillator Analysis predict about Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) for the period of 9-Day stands at 29.71% while the stochastic %D for the same period stands at 30.59%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. Ritter Pharmaceuticals, Inc. is headquartered in Los Angeles, California.

Previous Day Activity Analysis

On the last trading day, Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) opened the session at $0.36 and after going down -5.26% closed at $0.34. The stock lost -0.02 points in the last trade.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)’s stock fluctuated in the range of $0.340 and $0.380 during the previous active session. Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) traded with the volume of 1.46 Million with average volume of 584.03 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.04 and 28.59 respectively.

Currently the Insider Ownership of the shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) is at 0.2% and the shares outstanding are 15.7 Million.

Important Ratio Analysis

Some important ratios to consider here for Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) are discussed below:

Dividend yield of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 0 and 1.5 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 1.06 and 0 correspondingly.

The Quick Ratio of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stands at 2.1 while the Current Ratio depicts the value of 2.1.

Return on Assets ROA of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) is at -229% whereas, Return on Equity ROE and Return of Investment ROI of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stand at -369.6% and 0% respectively.

Stock Performance Analysis

The stock performance of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) on the basis of 5 day trade show the dip of -8.95% whereas, the monthly performance of the stock shows decrease of -38.59%.

The quarterly performance of the stock remained in red zone with the value of -45.41% while six month performance of the shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) remained bearish with the count of -68.74%.

The yearly and YTD performance of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) remained down at -80.01% and -87.31% respectively.